Logo CICANCER

CIC Events

Metabolic Control of Cell Fate in Regeneration and Cancer 16/06/2025

Metabolic Control of Cell Fate in Regeneration and Cancer

Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability 19/06/2025

Structure of Centromeric Chromatin and Its Consequences for Genome Stability

Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

The long journey to develop a drug against an “undruggable” target in cancer 03/07/2025

The long journey to develop a drug against an “undruggable” target in cancer

Laura Soucek — Vall d´Hebron, Barcelona

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies 07/07/2025

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies

Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

Decoding the RAS-PI3K-YAP signalling axis in CAFs during lung cancer  progression 10/07/2025

Decoding the RAS-PI3K-YAP signalling axis in CAFs during lung cancer progression

Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress. 14/07/2025

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.

Cristian Prieto — IBCII - Univ. Frankfurt



Past Events

Dissecting metastatic Bladder Cancer 05/06/2025

Dissecting metastatic Bladder Cancer

Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer 29/05/2025

Defining mechanisms of genomic evolution in cancer

Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London

Alernativas a la carrera académica 27/05/2025

Alernativas a la carrera académica

María José Lallena, Macarena Algarín, Judith Anido —

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond 22/05/2025

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond

Carlos Fernández de Larrea — Hospital Clínic de Barcelona